Navigating the Challenges of Lecanumab Treatment

This chapter examines the intricate ethical issues surrounding the use of lecanumab, based on a study observing patients for 18 months. It emphasizes the personal struggles faced by patients as they grapple with worsening symptoms and the decision to continue or discontinue the medication.